{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:01:33Z","timestamp":1784710893993,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0703-6","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T08:03:31Z","timestamp":1504512211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Chronic dialysis, NAT2 polymorphisms, and the risk of isoniazid-induced encephalopathy \u2013 case report and literature review"],"prefix":"10.1186","volume":"18","author":[{"given":"Stefan Matei","family":"Constantinescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Buysschaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Haufroid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Broly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Jadoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6925-1989","authenticated-orcid":false,"given":"Johann","family":"Morelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,4]]},"reference":[{"key":"703_CR1","unstructured":"World Health Organization. Global Tuberculosis Report 20th Edition; 2015."},{"key":"703_CR2","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0140-6736(65)91833-7","volume":"1","author":"P Adams","year":"1965","unstructured":"Adams P, White C. Isoniazid-induced encephalopathy. Lancet. 1965;1:680\u20132.","journal-title":"Lancet"},{"key":"703_CR3","first-page":"734","volume":"46","author":"G Miscoria","year":"1988","unstructured":"Miscoria G, Leneveu A, Walle C, et al. Application of a method of analysis using high performance liquid chromatography of isoniazid and acetylisoniazid to determine the phenotype of acetylation. Ann Biol Clin (Paris). 1988;46:734\u201340.","journal-title":"Ann Biol Clin (Paris)"},{"key":"703_CR4","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975\u201382.","journal-title":"Lancet"},{"key":"703_CR5","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1093\/ndt\/14.12.2857","volume":"14","author":"A Korzets","year":"1999","unstructured":"Korzets A, Gafter U. Tuberculosis prophylaxis for the chronically dialysed patient - yes or no? Nephrol Dial Transplant. 1999;14:2857\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"703_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/cid\/cit488","volume":"57","author":"DJ Horne","year":"2013","unstructured":"Horne DJ, Narita M, Spitters CL, Parimi S, Dodson S, Limaye AP. Challenging issues in tuberculosis in solid organ transplantation. Clin Infect Dis. 2013;57:1473\u201382.","journal-title":"Clin Infect Dis"},{"key":"703_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1159\/000187331","volume":"64","author":"MS Siskind","year":"1993","unstructured":"Siskind MS, Thienemann D, Kirlin L. Isoniazid-induced neurotoxicity in chronic dialysis patients: report of three cases and a review of the literature. Nephron. 1993;64:303\u20136.","journal-title":"Nephron"},{"key":"703_CR8","unstructured":"CDC 24\/7: Saving Lives, Protecting People. Atlanta: Centers for Disease Control and Prevention. Latent Tuberculosis Infection: A Guide for Primary Health Care Providers. Updated 2013 April 3 Available from: \n                    http:\/\/www.cdc.gov\/tb\/publications\/ltbi\/treatment.htm\n                    \n                  ."},{"key":"703_CR9","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0272-6386(96)90103-1","volume":"27","author":"R Kasama","year":"1996","unstructured":"Kasama R, Koch T, Canals-Navas C, Pitone JM. Vitamin B6 and hemodialysis: the impact of high-flux\/high-efficiency dialysis and review of the literature. Am J Kidney Dis. 1996;27:680\u20136.","journal-title":"Am J Kidney Dis"},{"key":"703_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF00210758","volume":"90","author":"M Mashimo","year":"1992","unstructured":"Mashimo M, Suzuki T, Abe M, et al. Molecular genotyping of N-acetylation polymorphism to predict phenotype. Hum Genet. 1992;90:139\u201343.","journal-title":"Hum Genet"},{"key":"703_CR11","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1128\/AAC.49.5.1733-1738.2005","volume":"49","author":"M Kinzig-Schippers","year":"2005","unstructured":"Kinzig-Schippers M, Tomalik-Scharte D, Jetter A, et al. Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses? Antimicrob Agents Chemother. 2005;49:1733\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"703_CR12","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00228-012-1429-9","volume":"69","author":"J Azuma","year":"2013","unstructured":"Azuma J, Ohno M, Kubota R, et al. NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy. Eur J Clin Pharmacol. 2013;69:1091\u2013101.","journal-title":"Eur J Clin Pharmacol"},{"key":"703_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12862-015-0543-6","volume":"15","author":"E Podgorn\u00e1","year":"2015","unstructured":"Podgorn\u00e1 E, Diallo I, Vangenot C, et al. Variation in NAT2 acetylation phenotypes is associated with differences in food-producing subsistence modes and ecoregions in Africa. BMC Evol Biol. 2015;15:263.","journal-title":"BMC Evol Biol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0703-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T09:06:05Z","timestamp":1536570365000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0703-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,4]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["703"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0703-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,4]]},"article-number":"282"}}